Unaudited Forward-Looking Statements Regarding Business Outlook | ||||||
(In millions, except per share data) | ||||||
|
| ||||||
Business Outlook |
| Three Months Ending December 29, 2018 | ||||
|
|
| GAAP Measure |
| Non-GAAP Adjustments |
| Non-GAAP Measure |
Gross margin |
| 60.0% |
| 0.0% - 0.5% |
| 60.0% - 60.5% |
|
|
|
|
|
|
|
|
Operating expenses |
| $111 |
| $23 |
| $88 |
|
|
|
|
|
|
|
|
Effective tax rate |
| 10.0% |
| 3.0% |
| 13.0% |
|
|
|
|
|
|
|
|
Diluted earnings per share - low |
| $0.39 |
| $0.52 |
| $0.91 |
|
|
|
|
|
|
|
|
Diluted earnings per share - high |
| $0.45 |
| $0.52 |
| $0.97 |
Silicon Laboratories Inc. | |||
Condensed Consolidated Balance Sheets | |||
(In thousands, except per share data) | |||
(Unaudited) | |||
|
| |||
|
| September 29,
|
| December 30,
|
Assets |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents | $ 225,326 |
| $ 269,366 |
Short-term investments | 376,603 |
| 494,657 |
Accounts receivable, net | 74,607 |
| 71,367 |
Inventories | 77,563 |
| 73,132 |
Prepaid expenses and other current assets | 46,952 |
| 39,120 |
Total current assets | 801,051 |
| 947,642 |
Property and equipment, net | 135,566 |
| 127,682 |
Goodwill | 396,689 |
| 288,227 |
Other intangible assets, net | 181,611 |
| 83,144 |
Other assets, net | 89,372 |
| 88,387 |
Total assets | $1,604,289 |
| $1,535,082 |
|
|
|
|
|
| Liabilities and Stockholders' Equity |
|
|
|
| Current liabilities: |
|
|
|
| Accounts payable | $ 43,647 |
| $ 38,851 |
| Deferred revenue and returns liability | 25,880 |
| -- |
| Deferred income on shipments to distributors | -- |
| 50,115 |
| Other current liabilities | 77,821 |
| 73,359 |
| Total current liabilities | 147,348 |
| 162,325 |
| Convertible debt | 351,457 |
| 341,879 |
| Other non-current liabilities | 57,777 |
| 77,862 |
| Total liabilities | 556,582 |
| 582,066 |
| Commitments and contingencies |
|
|
|
| Stockholders' equity: |
|
|
|
| Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued | -- |
| -- |
| Common stock – $0.0001 par value; 250,000 shares authorized; 43,147 and 42,707 shares issued and outstanding at September 29, 2018 and December 30, 2017, respectively | 4 |
| 4 |
| Additional paid-in capital | 103,169 |
| 102,862 |
| Retained earnings | 946,201 |
| 851,307 |
| Accumulated other comprehensive loss | (1,667) |
| (1,157) |
| Total stockholders' equity | 1,047,707 |
| 953,016 |
| Total liabilities and stockholders' equity | $1,604,289 |
| $1,535,082 |
